title: [The definition of a reference protocol for the clinical study of vertigo drugs].
abstract: The aim of this paper is to define the problems that arise in the clinical evaluation of drugs for the treatment of vertigo. Among these are the objective criteria used in defining vertigo and those used in evaluating efficacy of the drugs. The resulting protocol for a clinical study of vestibular drugs is a document that clarifies the debated points in the field, and above all furnishes guidelines for establishing uniformity in clinical studies. This, therefore, may become the reference protocol in Italy for clinical evaluations of drugs for the treatment of vertigo.
authors.affiliation: Istituto di Farmacologia, Università di Catania.
authors.forename: F
authors.initials: F
authors.lastname: Drago
authors.forename: A
authors.initials: A
authors.lastname: Agnoli
authors.forename: G
authors.initials: G
authors.lastname: Avanzini
authors.forename: G B
authors.initials: GB
authors.lastname: Azzena
authors.forename: S
authors.initials: S
authors.lastname: Conticello
authors.forename: I
authors.initials: I
authors.lastname: De Vincentiis
authors.forename: A
authors.initials: A
authors.lastname: Dufour
authors.forename: E
authors.initials: E
authors.lastname: Manni
authors.forename: E
authors.initials: E
authors.lastname: Mira
authors.forename: C
authors.initials: C
authors.lastname: Modugno
mesh_terms: D002985:Clinical Protocols; D006801:Humans; D007558:Italy; D014717:Vertigo / Q000175:diagnosis / Q000188:drug therapy*
vernacular_title: Definizione di un protocollo quadro per lo studio clinico di farmaci antivertiginosi.